We are live on ! Find out more
RMCM

Reynders McVeigh Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+1.12%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$704M
AUM Growth
+$17.6M
Cap. Flow
+$17.6M
Cap. Flow %
2.5%
Top 10 Hldgs %
34.59%
Holding
228
New
17
Increased
78
Reduced
95
Closed
3

Top Buys

Rank Stock Value
1
SJM icon
J.M. Smucker
SJM
+$2.94M
2
PYPL icon
PayPal
PYPL
+$2.45M
3
NVO
Novo Nordisk
NVO
+$2.38M
4
ADI icon
Analog Devices
ADI
+$1.8M
5
ADNT icon
Adient
ADNT
+$1.65M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.63M
2
IPGP icon
IPG Photonics
IPGP
+$1.49M
3
PRGO icon
Perrigo
PRGO
+$1.24M
4
KR icon
Kroger
KR
+$1.05M
5
GILD icon
Gilead Sciences
GILD
+$990K

Sector Composition

Rank Sector Weight
1 Healthcare 25.52%
2 Technology 19.56%
3 Industrials 16.26%
4 Consumer Staples 11.7%
5 Financials 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BP icon
201
BP
BP
$111B
$241K 0.03%
7,515
-2,021
-21% -$60.8K
ORA icon
202
Ormat Technologies
ORA
$7.04B
$241K 0.03%
+4,490
New +$218K
PX
203
DELISTED
Praxair Inc
PX
$241K 0.03%
2,060
-246
-11% -$29.2K
AVGO icon
204
Broadcom
AVGO
$1.98T
$239K 0.03%
13,500
-500
-4% -$8.66K
TROW icon
205
T. Rowe Price
TROW
$24.3B
$239K 0.03%
3,175
-50
-2% -$3.54K
XLK icon
206
State Street Technology Select Sector SPDR ETF
XLK
$122B
$238K 0.03%
+9,846
New +$235K
IVV icon
207
iShares Core S&P 500 ETF
IVV
$902B
$237K 0.03%
1,054
-50
-5% -$11K
TXN icon
208
Texas Instruments
TXN
$257B
$236K 0.03%
3,230
-500
-13% -$35.7K
PM icon
209
Philip Morris
PM
$290B
$234K 0.03%
2,557
UNH icon
210
UnitedHealth
UNH
$361B
$233K 0.03%
1,459
BX icon
211
Blackstone
BX
$110B
$228K 0.03%
8,450
-100
-1% -$2.6K
ETN icon
212
Eaton
ETN
$178B
$225K 0.03%
+3,350
New +$220K
WAB icon
213
Wabtec
WAB
$50.3B
$224K 0.03%
+2,700
New +$223K
TBI
214
Trueblue
TBI
$310M
$222K 0.03%
9,000
HSY icon
215
Hershey
HSY
$36.6B
$219K 0.03%
2,116
WLYB icon
216
John Wiley & Sons Class B
WLYB
$2.59B
$219K 0.03%
4,000
-100
-2% -$5.48K
FUL icon
217
H.B. Fuller
FUL
$3.34B
$217K 0.03%
4,500
VGK icon
218
Vanguard FTSE Europe ETF
VGK
$31B
$209K 0.03%
+4,363
New +$205K
AVNT icon
219
Avient
AVNT
$4.17B
$208K 0.03%
6,500
CDK
220
DELISTED
CDK Global, Inc.
CDK
$207K 0.03%
+3,464
New +$198K
KIM icon
221
Kimco Realty
KIM
$16.1B
$206K 0.03%
8,169
MNDT
222
DELISTED
Mandiant, Inc. Common Stock
MNDT
$204K 0.03%
17,110
-36,525
-68% -$474K
APD icon
223
Air Products & Chemicals
APD
$68.9B
$203K 0.03%
1,410
-439
-24% -$61.4K
FDS icon
224
Factset
FDS
$10.1B
$203K 0.03%
1,240
-95
-7% -$15.2K
INCY icon
225
Incyte
INCY
$24.5B
$201K 0.03%
+2,000
New +$195K

Similar funds

Reynders McVeigh Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Reynders McVeigh Capital Management held 228 positions worth $704M, up 2.6% from $686M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Reynders McVeigh Capital Management's Q4 2016 filing shows 17 new, 78 increased, 95 reduced and 3 closed positions. Its largest new stake was Adient: 31,202 shares worth $1.83M. The largest sale was Teva Pharmaceuticals, an estimated $1.63M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.

  • Reynders McVeigh Capital Management's largest Q4 2016 buy was Adient: 31,202 shares worth $1.83M.
  • Reynders McVeigh Capital Management added most to J.M. Smucker in Q4 2016, an estimated $2.94M increase.
  • Reynders McVeigh Capital Management's biggest Q4 2016 reduction was Teva Pharmaceuticals, cutting an estimated $1.63M.
  • Reynders McVeigh Capital Management fully exited Blackrock in Q4 2016, selling an estimated $275K.
  • Reynders McVeigh Capital Management's ten largest holdings make up 35% of its $704M portfolio in Q4 2016.
  • Reynders McVeigh Capital Management opened 17 new positions and closed 3 in Q4 2016.
  • Reynders McVeigh Capital Management's portfolio value rose 2.6% quarter-over-quarter to $704M.

Based on Reynders McVeigh Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.